,
Greetings from
Freyr Hungary
Holding an established pharmaceutical market with a comprehensive Regulatory framework, Hungary stands a competitive market for foreign medicinal and medical devices manufacturers for investments in the region. To get the market access, manufacturers must comply with regulations of Hungary’s National Institute of Pharmacy and Nutrition (OGYEI). Not only the stringent regulations inclusive of language barriers, but also the complex Regulatory procedural challenges demand a special attention from manufacturers, who are willing to enter the region.
Leveraging our cutting-edge knowledge on Hungary’s Regulatory Affairs, Freyr, as a specialized Regulatory partner, assists foreign manufacturers to streamline medicinal product’s approval process cost-effectively and in a timely manner. Freyr’s Regulatory services in Hungary span across:
- Medical Devices
- Pharmaceuticals / Drugs
- Biologics
- Cosmetics
Industries We Serve in Hungary
Hungary operates within the EU pharmaceutical regulatory framework, with the National Institute of Pharmacy and Nutrition (OGYÉI) acting as the national competent authority. While marketing authorizations are granted through EU-wide or coordinated procedures, sponsors must manage Hungary-specific administrative, linguistic, and post-authorization requirements to ensure timely approval, launch, and ongoing compliance.
Freyr Offerings
- Strategic Regulatory Consulting
- Strategic business development focusing on the European market
- Regulatory roadmap for market access
- Regulatory Affairs & Regulatory intelligence
- Registration pathways and license management services
- End-to-end operational support
- Dossier preparation, review and management
- Regulatory Submissions
- Market assessments
- In-country representation
Freyr Advantages
- Expert Regulatory team with proven global RA expertise
- Proactive and Collaborative approach
- Quick turnarounds and faster time-to-market
- Keeping abreast with region-specific legislation and Regulatory guidelines